In a filing, Centessa Pharmaceuticals plc ADR revealed its Chief Business Officer Weinhoff Gregory M unloaded Company’s shares for reported $0.13 million on May 27 ’25. In the deal valued at $12.82 per share,10,000 shares were sold. As a result of this transaction, Weinhoff Gregory M now holds 122,279 shares worth roughly $1.48 million.
Then, Weinhoff Gregory M bought 10,000 shares, generating $128,225 in total proceeds.
Before that, SAHA SAURABH sold 55,000 shares. Centessa Pharmaceuticals plc ADR shares valued at $699,110 were divested by the Chief Executive Officer at a price of $12.71 per share. As a result of the transaction, SAHA SAURABH now holds 221,017 shares, worth roughly $2.68 million.
Needham initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to a Buy in a research note published on May 28, 2025; the price target was $35. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Piper Sandler began covering CNTA with “an Overweight” recommendation on March 31, 2025. TD Cowen started covering the stock on January 07, 2025. It rated CNTA as “a Buy”.
Price Performance Review of CNTA
On Tuesday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock jump 1.51% to $12.12. Over the last five days, the stock has lost -9.28%. Centessa Pharmaceuticals plc ADR shares have fallen nearly -27.64% since the year began. Nevertheless, the stocks have risen 35.87% over the past one year.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2025-05-30, dropping by 64499.0 shares to a total of 5.26 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 5.33 million shares. There was a decline of -1.23%, which implies that there is a negative sentiment for the stock.
